Ads
related to: t-cell therapy- How This Treatment Works
Get Info On Lymphoma
Treatment & See How It Works
- Safety & Side Effects
Read Important Safety And Possible
Side Effects Information.
- Treatment Centers
Find A Treatment Center Near You
FDA-Approved Treatment Option
- Take The Quiz
Find Out If This Treatment Option
Is Right For You
- Clinical Trial Results
Find Info On Clinical Trials
For This Treatment Option.
- Dosing Information
View Recommended Dosing Schedules
For This Treatment Option.
- How This Treatment Works
Search results
EU regulator mandates label updates on CAR-T cancer therapies
WHTC 1450 Holland· 4 days ago(Reuters) - The European health regulator said on Friday product information for a class of cancer...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caribou...
Morningstar· 3 days agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Caribou Biosciences, Inc. ("Caribou" or the "Company") (NASDAQ: CRBU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 2 days agoMonday, the cell therapy-focused company announced that updated data from the ongoing Phase 1/2...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters· 4 days agoThe European health regulator said on Friday product information for a class of cancer therapies...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks· 21 hours agoFree Report) reported updated results from a cohort of an ongoing phase I/II study evaluating its lead clinical candidate MB-106 in patients with Waldenstrom macroglobulinemia (WM), a rare form ...
EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL
Pharmaceutical Technology via Yahoo Finance· 2 days agoBased on the latest STARGLO trial results, there is potential to extend Columvi into earlier lines...
Mozart Therapeutics doses first patients in trial of MTX-101 for autoimmune diseases
Clinical Trials Arena via Yahoo Finance· 17 hours agoUS-based biopharmaceutical company Mozart Therapeutics has dosed the first subjects in its Phase...
Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
Digital Journal· 15 hours agoImmunotherapy, the latest technology in the war on cancer, can come in various forms; including: checkpoint inhibitors, Chimeric Antigen Receptor ("CAR") T-Cell< ...
Drug reprograms immune responses to target glioblastoma
Medical Xpress· 13 hours agoInvestigators from Northwestern University Feinberg School of Medicine and The University of Texas...
Piper Sandler keeps 'Overweight' on Allogene stock, highlights CAR-T potential By Investing.com
Investing.com· 2 days agoOn Monday, Piper Sandler reaffirmed its Overweight rating on Allogene Therapeutics (NASDAQ:ALLO)...
Ads
related to: t-cell therapy